Insights+: EMA Marketing Authorization of New Drugs in February 2024

Shots: The EMA approved 5 BLA and 8 New Chemical Entities in February 2024, leading to treatments for patients and advances in the healthcare industry In February 2024, the major highlighted drugs were Reblozyl to treat Transfusion-Dependent Anemia and Velsipity for the treatment of Severely Active Ulcerative Colitis PharmaShots has compiled a list of a total…

BySenior EditorMarch 20, 2024

TOP 20

Top 20 Immunology Companies Based on 2022 Immunology Segment Total Revenue

Shots: With the noble responsibility of ensuring a healthy society on their shoulders, biopharma companies focused on Immunology are diligently working to develop treatments, vaccines, antibodies, and drugs The global Immunology market was valued at $97.93B in 2021 and is anticipated to reach $184.21B by 2029 with a CAGR of 8.5 percent. In 2022, AbbVie…

ByPrince GiriAugust 14, 2023

Insights+: EMA Marketing Authorization of New Drugs in February 2024

Top 20 Immunology Companies Based on 2022 Immunology Segment Total Revenue

Contact US

FOLLOW US